Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.